X4 Pharmaceuticals, Inc. (XFOR)
Develops oral medicines to treat rare immune system diseases like WHIM syndrome.
$3.93-0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+145.6%
The outlook
X4 Pharmaceuticals is trading at $3.93, positioned three-quarters of the way up its 52-week range with mixed momentum against its moving averages. Analysts see substantial upside, with an average price target implying roughly 195% above current levels, while the overall sentiment leans bullish.
What’s behind the score
Price trendMixed vs its moving averages
52-week range74% of the way from its 52-week low to high
Price targetAvg target +195% vs current price
Analyst price target
~12-month · 5 analysts$11.60average target+195.2% vs now
Now $3.93
Low $10.00High $13.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$370.7M
52-wk high
$4.83
52-wk low
$1.35
50-day avg
$3.98
200-day avg
$3.84
Trailing P/E
—